Drug Side Effects

INTESTINAL SEPSIS

This adverse event was reported 154 times

These drugs are most commonly taken by patients reporting INTESTINAL SEPSIS:

# Drug Count
0 ADALIMUMAB 91
1 ETANERCEPT 62
2 ABATACEPT 61
3 RITUXIMAB 61
4 TOCILIZUMAB 61
5 INFLIXIMAB 60
6 LEFLUNOMIDE 59
7 METHOTREXATE SODIUM 59
8 SULFASALAZINE 59
9 TOFACITINIB 57
See all common drugs associated with INTESTINAL SEPSIS

INTESTINAL SEPSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GOLD 37 0.0099
1 CANAKINUMAB 36 0.0047
2 ANAKINRA 37 0.0035
3 ACETYLSALICYCLIC ACID 1 0.0034
4 MINOCYCLINE HYDROCHLORIDE 35 0.0032
5 DOXYCLYCLINE HYCLATE 16 0.0017
6 DAUNORUBICIN HYDROCHLORIDE 1 0.0012
7 SULFASALAZINE 59 0.0011
8 TOCILIZUMAB 61 0.0009
9 HYDROXYCHLOROQUINE SULFATE 55 0.0008
See all drugs enriched for association with INTESTINAL SEPSIS

These drug classes are most commonly taken by patients reporting INTESTINAL SEPSIS:

# Drug class Count
0 Tumor Necrosis Factor Blocker [EPC] 63
1 CD20-directed Cytolytic Antibody [EPC] 62
2 Interleukin-6 Receptor Antagonist [EPC] 61
3 Selective T Cell Costimulation Modulator [EPC] 61
4 Aminosalicylate [EPC] 59
5 Antirheumatic Agent [EPC] 59
6 Folate Analog Metabolic Inhibitor [EPC] 55
7 Interleukin-1 Receptor Antagonist [EPC] 37
8 Standardized Chemical Allergen [EPC] 37
9 Opioid Agonist [EPC] 34
See all common drug classes associated with INTESTINAL SEPSIS

INTESTINAL SEPSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 37 0.0035
1 Standardized Chemical Allergen [EPC] 37 0.0032
2 Interleukin-6 Receptor Antagonist [EPC] 61 0.0008
3 Antirheumatic Agent [EPC] 59 0.0007
4 Aminosalicylate [EPC] 59 0.0007
5 Selective T Cell Costimulation Modulator [EPC] 61 0.0007
6 Tetracycline-class Drug [EPC] 23 0.0005
7 CD20-directed Cytolytic Antibody [EPC] 62 0.0004
8 GLP-2 Analog [EPC] 2 0.0003
9 Echinocandin Antifungal [EPC] 1 0.0002
See all drug classes enriched for association with INTESTINAL SEPSIS